MitraClip装置によるトランスキャセータミトラルバルブエッジツーエッジ修復の有効性と安全性
Shamir R Mehta1,2, Anita Asgar3, Robert Boone4
1Population Health Research Institute, Hamilton, Ontario, Canada.
CJC open
|September 2, 2025
まとめ
加拿大人の患者では,ミトラス・トランスキャセターのエッジ・トゥ・エッジ修復 (M- TEER) によって,ミトラス・リグルジテーション (MR) と心不全の入院が著しく減少しました. この安全で効果的な治療法により,退行性 MR型と機能性 MR型の両方の機能性クラスが改善されました.
科学分野:
- 心血管医学
- 介入心臓科
- 医療機器
背景:
- 側頭管横管端から端まで修復 (M-TEER) は,症状性側頭管反吐 (MR) の確立された治療法である.
- M-TEERの結果に関するカナダの実際のデータは以前には利用できませんでした.
研究 の 目的:
- M-TEERの有効性と安全性をカナダの集団で評価する.
- M-TEERがMRの重症度,心不全の入院,機能性クラスに与える影響を評価する.
主な方法:
- カナダの11のセンターでM-TEERをMitraClip装置で受けた1191人の患者が参加した観察研究.
- 個々のM-TEERデータベースから集約されたデータを集約して,国家登録を作成します.
- 主要アウトカム:M-TEER前とM-TEER後1年までのMRの重症度 2次結果:HF入院とNYHA機能クラス
主要な成果:
- M- TEER後の11. 0%に対して,MR≥3+の97. 3%;P< 0. 001) が有意に減少した.
- HF入院の有意な減少 (M-TEER前対後10. 3%,P < 0. 001),MRの病因に一致する.
- NYHA機能クラスにおける顕著な改善 (III- IV HFのクラス前対M- TEERの16. 6%; P < 0. 001).
- シングルリーフレット脱落 (1. 0%) とミトラ弁手術の必要性 (2. 2%) といった稀な合併症の割合は低い.
結論:
- M-TEERは,現実のカナダ環境で,MRの重症性を持続的に軽減します.
- 心不全の入院が著しく減少し,機能能力が向上しました.
- M- TEERは,退行性および機能性MR患者の両方に高い安全性プロファイルと一貫した利点を示しています.
関連する概念動画
Mitral Regurgitation III: Medical Management
28
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
28
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
Mitral Stenosis II: Clinical features and Diagnostic Tests
37
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
50
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
50
Mitral Regurgitation I: Introduction
55
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
55


